602 related articles for article (PubMed ID: 31606236)
1. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
2. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
[TBL] [Abstract][Full Text] [Related]
3. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
[TBL] [Abstract][Full Text] [Related]
4. Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.
Barbour SJ; Coppo R; Zhang H; Liu ZH; Suzuki Y; Matsuzaki K; Katafuchi R; Er L; Espino-Hernandez G; Kim SJ; Reich HN; Feehally J; Cattran DC;
JAMA Intern Med; 2019 Jul; 179(7):942-952. PubMed ID: 30980653
[TBL] [Abstract][Full Text] [Related]
5. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
Cai Q; Shi S; Wang S; Ren Y; Hou W; Liu L; Lv J; Haas M; Zhang H
Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
[TBL] [Abstract][Full Text] [Related]
6. The MEST score provides earlier risk prediction in lgA nephropathy.
Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
[TBL] [Abstract][Full Text] [Related]
7. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
[TBL] [Abstract][Full Text] [Related]
8. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy.
Chen T; Li X; Li Y; Xia E; Qin Y; Liang S; Xu F; Liang D; Zeng C; Liu Z
Am J Kidney Dis; 2019 Sep; 74(3):300-309. PubMed ID: 31031086
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
Yang JYC; Sarwal RD; Fervenza FC; Sarwal MM; Lafayette RA
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510053
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
11. Arteriolar C4d in IgA Nephropathy: A Cohort Study.
Faria B; Canão P; Cai Q; Henriques C; Matos AC; Poppelaars F; Gaya da Costa M; Daha MR; Silva R; Pestana M; Seelen MA
Am J Kidney Dis; 2020 Nov; 76(5):669-678. PubMed ID: 32439421
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.
Shin JR; Kim SM; Yoo JS; Park JY; Kim SK; Cho JH; Jeong KH; Lee TW; Ihm CG
Korean J Intern Med; 2014 May; 29(3):334-40. PubMed ID: 24851068
[TBL] [Abstract][Full Text] [Related]
13. Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort Study.
Zhang X; Luo F; Chen R; Shen J; Liu X; Shi Y; Yang Q; Huang T; Li H; Hu Y; Wan Q; Chen C; Jia N; Cao Y; Li Y; Zhao H; Su L; Gao P; Xu X; Nie S; Hou FF
Am J Kidney Dis; 2023 Apr; 81(4):416-424.e1. PubMed ID: 36252881
[TBL] [Abstract][Full Text] [Related]
14. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.
Liu LL; Jiang Y; Wang LN; Liu N
Clin Exp Immunol; 2012 Aug; 169(2):148-55. PubMed ID: 22774989
[TBL] [Abstract][Full Text] [Related]
15. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
16. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
[TBL] [Abstract][Full Text] [Related]
17. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
Zhu B; Liu WH; Lin Y; Li Q; Yu DR; Jiang F; Tang XL; Du YY; Yin JZ; Li XF; Zhong YZ; Wang WR; Sun Y; Zhang MJ; Gao YC; Yuan CY; Zhu CF; Cheng XX
Am J Nephrol; 2022; 53(6):455-469. PubMed ID: 35576899
[TBL] [Abstract][Full Text] [Related]
18. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
[TBL] [Abstract][Full Text] [Related]
19. External Validation of the International IgA Nephropathy Prediction Tool.
Zhang J; Huang B; Liu Z; Wang X; Xie M; Guo R; Wang Y; Yu D; Wang P; Zhu Y; Ren J
Clin J Am Soc Nephrol; 2020 Aug; 15(8):1112-1120. PubMed ID: 32616496
[TBL] [Abstract][Full Text] [Related]
20. Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status.
Gong S; Jin S; Li Y; Jiang W; Zhang Z; Shen Z; Wang J; Zhou H; Liu X; Xu X; Ding X; Shi Y; Liu H
Front Immunol; 2021; 12():769802. PubMed ID: 35003086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
